Glenmark Pharma arm enters into licensing agreement with Lotus Intl

Glenmark Pharma arm enters into licensing agreement with Lotus Intl

by admin- Thursday, January 20th, 2022 03:45:00 PM

Glenmark Pharmaceuticals introduced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an extraordinary licensing agreement with Lotus International Pte. Ltd., a wholly owned subsidiary of Lotus Pharmaceutical Co., Ltd. (Lotus), for commercializing its revolutionary nasal spray Ryaltris in Singapore, Hong Kong and Vietnam.

News Updates